Menu

Welcome to the Anteris Investor Center, your hub for financial updates and company news.

Welcome to the Anteris Investor Centre, your hub for financial updates and company news.

Financial Filings

Access the latest SEC Filings (Nasdaq: AVR) and ASX Announcements (ASX: AVR) 

SEC Filings

Filing Date Form Description Actions
  • NOV 10
    Form: DEF 14A
    Other definitive proxy statements
  • NOV 10
    Form: ARS
    Annual Report to Security Holders
  • NOV 07
    Form: D
    Notice of Exempt Offering of Securities
View all

ASX Announcements
View all

Corporate Profile

Anteris Technologies is a structural heart company committed to designing, developing, and commercializing innovative medical devices.

 

Designed with physicians for patients, our DurAVR® Transcatheter Heart Valve (THV) uses a single-piece, native-shaped biomimetic design built to mimic the performance of a healthy aortic valve. 

Anteris Technologies is a structural heart company

Sign Up for ASX Investor Email Alerts

Sign up

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Our Technologies

The DurAVR® THV System

The DurAVR® Transcatheter Heart Valve (THV) System has delivered paradigm-shifting hemodynamic performance combined with the deliverability performance of a balloon-expandable system. The System includes the DurAVR® Transcatheter Heart Valve, the ADAPT® anti-calcification tissue, and the ComASUR® Delivery System.  

Our Technology

For more information, contact Investor Relations 
investors@anteristech.com